Maravai Lifesciences Holdings Stock Today
| MRVI Stock | USD 2.24 0.03 1.32% |
PerformanceVery Weak
| Odds Of DistressLow
|
Maravai Lifesciences is trading at 2.24 as of the 24th of March 2025. This is a 1.32 percent decrease since the beginning of the trading day. The stock's open price was 2.27. Maravai Lifesciences has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. Maravai LifeSciences Holdings, Inc. The company has 143.65 M outstanding shares of which 10.3 M shares are now shorted by private and institutional investors with about 2.49 trading days to cover. More on Maravai Lifesciences Holdings
Moving together with Maravai Stock
| 0.8 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.92 | ME | 23Andme Holding | PairCorr |
| 0.89 | VANI | Vivani Medical | PairCorr |
Moving against Maravai Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Maravai Stock Highlights
| CoFounder Chairman | Carl Hull |
| Thematic Idea | Pharmaceutical Products (View all Themes) |
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Maravai Lifesciences Holdings (MRVI) is traded on NASDAQ Exchange in USA. It is located in 10770 Wateridge Circle, San Diego, CA, United States, 92121 and employs 570 people. Maravai Lifesciences is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 576.07 M. Maravai Lifesciences conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 143.65 M outstanding shares of which 10.3 M shares are now shorted by private and institutional investors with about 2.49 trading days to cover.
Maravai Lifesciences Holdings currently holds about 617.45 M in cash with 7.46 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Maravai Lifesciences Probability Of Bankruptcy
Ownership AllocationMaravai Lifesciences maintains a total of 143.65 Million outstanding shares. The majority of Maravai Lifesciences outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Maravai Lifesciences Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Maravai Lifesciences. Please pay attention to any change in the institutional holdings of Maravai Lifesciences as this could imply that something significant has changed or is about to change at the company. Also note that almost one hundred seventy-two thousand three hundred eighty-two invesors are currently shorting Maravai Lifesciences expressing very little confidence in its future performance.
Check Maravai Ownership Details
Maravai Lifesciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Maravai Lifesciences market risk premium is the additional return an investor will receive from holding Maravai Lifesciences long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.24) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (3.18) |
Maravai Stock Against Markets
Maravai Lifesciences Corporate Management
| Kurt Oreshack | General VP | Profile | |
| Christine Dolan | Executive Technologies | Profile | |
| Brian Neel | Chief Production | Profile | |
| Peter Leddy | Executive Officer | Profile | |
| Christopher Benoit | Executive Enzymes | Profile | |
| Becky Buzzeo | Executive Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.